Ontario’s agriculture and agri-food sector is strong and growing. However, the demands and challenges the sector is faced with are also growing. In the context of enhancing a socially and environmentally responsible industry, genomics-based innovations and technologies provide significant opportunities to advance Ontario’s agriculture and agri-food sector.
Resulting from the inaugural Canada SynBio 2018 conference and strategic workshop held in March, the Discussion Paper, The Present and Future State of Synthetic Biology in Canada, is now available
The theme of this year’s annual report, Tomorrow today, reflects the incredibly fast pace in which technological innovation is changing the future. We invite you to review it, to learn more about these exciting advancements for both the field of genomics and the province of Ontario.
Synthetic biology is the science of building simple organisms or “biological apps” to make manufacturing more green, energy production more sustainable, agriculture more robust, and medicine more powerful and precise. The US and UK are nurturing synthetic biology as humanity’s next technological frontier. It will take bold and decisive action for Ontario to seize this opportunity.
In this report, the Ontario Chamber of Commerce identifies the central challenges to Ontario’s health sector growth and makes recommendations on how to create an environment that supports success.
Ontario Bioscience Innovation Organization (OBIO) released its report of recommendations for Canada to compete in the world market while delivering better health outcomes and creating high quality jobs for Canadian talent.
Did you know that conservative estimates put annual revenues of Ontario’s life sciences sector at $40.5B, directly contributing $21.6B to Ontario’s GDP? See how the success of Ontario’s life sciences sector impacts Canada’s future prosperity.
With support from the Data for Health Advisory Group and the OPMN, Ontario Genomics has released the” Call for an Ontario Health Data Ecosystem” report to investigate affordable and feasible mechanisms for Ontario to remain competitive with global benchmarks in the emerging age of data-driven medicine and research. This paper’s ultimate recommendation is a call for an enabling mechanism–the formation of a health data coalition. This coalition would consist of leading organizations across the research and clinical data continuum, as well as the Ministry of Research, Innovation and Science and Ministry of Health and Long-Term Care, with the aim to develop some foundational data sharing policies to facilitate the exchange of data assets.